-
Something wrong with this record ?
Poly(ethylene oxide monomethyl ether)- block-poly(propylene succinate) Nanoparticles: Synthesis and Characterization, Enzymatic and Cellular Degradation, Micellar Solubilization of Paclitaxel, and in Vitro and in Vivo Evaluation
A. Jäger, E. Jäger, Z. Syrová, T. Mazel, L. Kováčik, I. Raška, A. Höcherl, J. Kučka, R. Konefal, J. Humajova, P. Poučková, P. Štěpánek, M. Hrubý,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Micelles MeSH
- Mice, Inbred BALB C MeSH
- Mice MeSH
- Cell Line, Tumor MeSH
- Nanoparticles adverse effects chemistry metabolism MeSH
- Paclitaxel administration & dosage pharmacokinetics MeSH
- Polyesters chemical synthesis chemistry MeSH
- Polyethylene Glycols chemistry MeSH
- Polypropylenes chemistry MeSH
- Antineoplastic Agents administration & dosage pharmacokinetics MeSH
- Succinates chemistry MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Polyester-based nanostructures are widely studied as drug-delivery systems due to their biocompatibility and biodegradability. They are already used in the clinic. In this work, we describe a new and simple biodegradable and biocompatible system as the Food and Drug Administration approved polyesters (poly-ε-caprolactone, polylactic acid, and poly(lactic- co-glycolic acid)) for the delivery of the anticancer drug paclitaxel (PTX) as a model drug. A hydrophobic polyester, poly(propylene succinate) (PPS), was prepared from a nontoxic alcohol (propylene glycol) and monomer from the Krebs's cycle (succinic acid) in two steps via esterification and melt polycondensation. Furthermore, their amphiphilic block copolyester, poly(ethylene oxide monomethyl ether)- block-poly(propylene succinate) (mPEO- b-PPS), was prepared by three steps via esterification followed by melt polycondensation and the addition of mPEO to the PPS macromolecules. Analysis of the in vitro cellular behavior of the prepared nanoparticle carriers (NPs) (enzymatic degradation, uptake, localization, and fluorescence resonance energy-transfer pair degradation studies) was performed by fluorescence studies. PTX was loaded to the NPs of variable sizes (30, 70, and 150 nm), and their in vitro release was evaluated in different cell models and compared with commercial PTX formulations. The mPEO- b-PPS copolymer analysis displays glass transition temperature < body temperature < melting temperature, lower toxicity (including the toxicity of their degradation products), drug solubilization efficacy, stability against spontaneous hydrolysis during transport in bloodstream, and simultaneous enzymatic degradability after uptake into the cells. The detailed cytotoxicity in vitro and in vivo tumor efficacy studies have shown the superior efficacy of the NPs compared with PTX and PTX commercial formulations.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028493
- 003
- CZ-PrNML
- 005
- 20190820085331.0
- 007
- ta
- 008
- 190813s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.biomac.8b00048 $2 doi
- 035 __
- $a (PubMed)29601729
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Jäger, Alessandro $u Institute of Macromolecular Chemistry , Heyrovsky Square 2 , 162 06 Prague , Czech Republic.
- 245 10
- $a Poly(ethylene oxide monomethyl ether)- block-poly(propylene succinate) Nanoparticles: Synthesis and Characterization, Enzymatic and Cellular Degradation, Micellar Solubilization of Paclitaxel, and in Vitro and in Vivo Evaluation / $c A. Jäger, E. Jäger, Z. Syrová, T. Mazel, L. Kováčik, I. Raška, A. Höcherl, J. Kučka, R. Konefal, J. Humajova, P. Poučková, P. Štěpánek, M. Hrubý,
- 520 9_
- $a Polyester-based nanostructures are widely studied as drug-delivery systems due to their biocompatibility and biodegradability. They are already used in the clinic. In this work, we describe a new and simple biodegradable and biocompatible system as the Food and Drug Administration approved polyesters (poly-ε-caprolactone, polylactic acid, and poly(lactic- co-glycolic acid)) for the delivery of the anticancer drug paclitaxel (PTX) as a model drug. A hydrophobic polyester, poly(propylene succinate) (PPS), was prepared from a nontoxic alcohol (propylene glycol) and monomer from the Krebs's cycle (succinic acid) in two steps via esterification and melt polycondensation. Furthermore, their amphiphilic block copolyester, poly(ethylene oxide monomethyl ether)- block-poly(propylene succinate) (mPEO- b-PPS), was prepared by three steps via esterification followed by melt polycondensation and the addition of mPEO to the PPS macromolecules. Analysis of the in vitro cellular behavior of the prepared nanoparticle carriers (NPs) (enzymatic degradation, uptake, localization, and fluorescence resonance energy-transfer pair degradation studies) was performed by fluorescence studies. PTX was loaded to the NPs of variable sizes (30, 70, and 150 nm), and their in vitro release was evaluated in different cell models and compared with commercial PTX formulations. The mPEO- b-PPS copolymer analysis displays glass transition temperature < body temperature < melting temperature, lower toxicity (including the toxicity of their degradation products), drug solubilization efficacy, stability against spontaneous hydrolysis during transport in bloodstream, and simultaneous enzymatic degradability after uptake into the cells. The detailed cytotoxicity in vitro and in vivo tumor efficacy studies have shown the superior efficacy of the NPs compared with PTX and PTX commercial formulations.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a protinádorové látky $x aplikace a dávkování $x farmakokinetika $7 D000970
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a micely $7 D008823
- 650 _2
- $a nanočástice $x škodlivé účinky $x chemie $x metabolismus $7 D053758
- 650 _2
- $a paclitaxel $x aplikace a dávkování $x farmakokinetika $7 D017239
- 650 _2
- $a polyestery $x chemická syntéza $x chemie $7 D011091
- 650 _2
- $a polyethylenglykoly $x chemie $7 D011092
- 650 _2
- $a polypropyleny $x chemie $7 D011126
- 650 _2
- $a sukcináty $x chemie $7 D013386
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Jäger, Eliézer $u Institute of Macromolecular Chemistry , Heyrovsky Square 2 , 162 06 Prague , Czech Republic.
- 700 1_
- $a Syrová, Zdeňka
- 700 1_
- $a Mazel, Tomas
- 700 1_
- $a Kováčik, Lubomír
- 700 1_
- $a Raška, Ivan
- 700 1_
- $a Höcherl, Anita $u Institute of Macromolecular Chemistry , Heyrovsky Square 2 , 162 06 Prague , Czech Republic.
- 700 1_
- $a Kučka, Jan $u Institute of Macromolecular Chemistry , Heyrovsky Square 2 , 162 06 Prague , Czech Republic.
- 700 1_
- $a Konefal, Rafal $u Institute of Macromolecular Chemistry , Heyrovsky Square 2 , 162 06 Prague , Czech Republic.
- 700 1_
- $a Humajova, Jana $u Institute of Biophysics and Informatics, First Faculty of Medicine , Charles University , Salmovska 1 , 120 00 Prague , Czech Republic.
- 700 1_
- $a Poučková, Pavla $u Institute of Biophysics and Informatics, First Faculty of Medicine , Charles University , Salmovska 1 , 120 00 Prague , Czech Republic.
- 700 1_
- $a Štěpánek, Petr $u Institute of Macromolecular Chemistry , Heyrovsky Square 2 , 162 06 Prague , Czech Republic.
- 700 1_
- $a Hrubý, Martin $u Institute of Macromolecular Chemistry , Heyrovsky Square 2 , 162 06 Prague , Czech Republic.
- 773 0_
- $w MED00006456 $t Biomacromolecules $x 1526-4602 $g Roč. 19, č. 7 (2018), s. 2443-2458
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29601729 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190820085606 $b ABA008
- 999 __
- $a ok $b bmc $g 1433642 $s 1066953
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 19 $c 7 $d 2443-2458 $e 20180411 $i 1526-4602 $m Biomacromolecules $n Biomacromolecules $x MED00006456
- LZP __
- $a Pubmed-20190813